查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1504994

睡眠呼吸中止症用设备市场，占有率，规模，趋势，产业分析报告:各诊断设备，各治疗设备，各终端用户，各地区:各市场区隔预测，2024年～2032年

Sleep Apnea Devices Market Share, Size, Trends & Industry Analysis Report, By Diagnostic Devices; By Therapeutic Devices; By End User; By Region: Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

根据 Polaris Market Research 的最新报告，到 2032 年，全球睡眠呼吸中止设备市场规模预计将达到 79.6 亿美元，2024 年至 2032 年复合年增长率为 5.9%。 2023年，全球睡眠呼吸中止设备产业收入以PAP（气道正压通气）为主。北美是2017年全球市场收入的主要贡献者。

睡眠呼吸中止症是一种在睡眠期间呼吸过程中断，导致大脑和身体缺氧的疾病。阻塞性睡眠呼吸中止症（OSA）是最常见的睡眠呼吸中止症类型，呼吸道阻塞是主要原因。其他睡眠呼吸中止症包括中枢性睡眠呼吸中止症和混合性睡眠呼吸中止症。为了避免此类疾病，必须对患者进行诊断测试并对适当的治疗设备进行分类。睡眠呼吸中止症在老年人中更为常见。在许多情况下，由于疾病的非特异性表现和患者缺乏意识等因素，睡眠呼吸中止症仍未被诊断出来。

这种疾病的发生率不断增加、个人反应能力不断增强、老年人口不断增长，以及对正确诊断和有效治疗的需求不断增长，是推动增长的一些关键因素。此外，提高舒适度和安全性的技术进步预计将增加该设备的利用率，特别是在北美等新兴经济体，这预计将成为市场发展的驱动力。

过去十年，睡眠呼吸中止症诊断产业经历了快速成长。这一增长是由睡眠呼吸中止症设备的不断进步所推动的。根据世界卫生组织 (WHO) 的报告，大约有 1 亿人患有睡眠呼吸中止症。此外，阻塞性睡眠呼吸中止症是一种对健康产生负面影响的慢性疾病。根据国家健康睡眠意识计画的报告，光在美国就有大约 2500 万人受到这种疾病的影响。

睡眠呼吸中止症的发生会急剧增加其他疾病的风险，如糖代谢异常、忧郁症、糖尿病、高血压、全身性高血压、心臟病和中风。所有这些疾病都会增加国家医疗保健总费用的负担。人们对睡眠呼吸中止症的认识不断提高以及睡眠呼吸中止症治疗设备的广泛使用预计将在不久的将来加速收入成长。

预计北美在 2017 年占据最高的市场占有率。如此大的市占率主要是由于睡眠呼吸障碍（SDB）的高发生率。此外，人们越来越意识到新颖且技术先进的睡眠呼吸中止症设备正在推动北美市场的成长。

亚太市场预计将成为预测期内成长最快的产业。诊所数量的增加和未确诊患者数量的增加预计将在市场上形成利润丰厚的成长机会。该地区的领先公司正致力于制定有利的政策，透过采用先进且具有成本效益的设备来扩大消费者基础，预计这将在预测期内为市场提供强劲的成长机会。

睡眠呼吸中止症设备市场报告中介绍的一些知名公司包括 Fisher & Paykel Healthcare（纽西兰）、Koninklijke Philips（荷兰）、ResMed（美国）、Compumedics（澳洲）、Whole You（美国），其中包括 BMC Medical （中国）、Braebon Medical（加拿大）、Lowenstein Medical（德国）、Drive DeVilbiss Healthcare（美国）和SomnoMed（澳洲）。这些公司推出新产品，并与其他市场领导者合作，创新并推出新产品，以满足消费者不断增长的需求和需求。

目录

第1章 概要与范围

  • 调查目标和范围
  • 调查的前提
  • 调查手法
    • 主要资料来源
    • 二次资料来源
  • 重要的要点
  • 利害关係者

第2章 执行概要

第3章 睡眠呼吸中止症用设备市场洞察

  • 睡眠呼吸中止症用设备-产业概要
  • 睡眠呼吸中止症用设备-生态系统分析
  • 睡眠呼吸中止症用设备市场动态
    • 睡眠呼吸中止症用设备-市场力量
      • 睡眠呼吸中止症用设备推动市场要素分析
      • 睡眠呼吸中止症用设备阻碍市场要素/课题分析
      • 睡眠呼吸中止症用设备市场机会分析
  • 产业分析-波特的五力分析
    • 供应商谈判力
    • 买方议价能力
    • 替代品的威胁
    • 新加入厂商的威胁
    • 竞争的程度
  • 睡眠呼吸中止症用设备市场PEST分析
  • 睡眠呼吸中止症用设备市场价值链分析
  • 睡眠呼吸中止症用设备产业趋势
  • 竞争排行榜分析，2017年

第4章 睡眠呼吸中止症用设备市场规模与预测，2018～2026年，各诊断设备

  • 主要调查结果
  • 多导睡眠图设备 (PSG)
  • 呼吸测谎仪
  • 脉搏血氧计
  • 体动记录仪

第5章 睡眠呼吸中止症用设备市场规模与预测，2018～2026年，各治疗设备

  • 主要调查结果
  • 正压呼吸器(PAP)设备
  • 氧气设备
  • 口腔设备
  • 自适应伺服通风(ASV)设备

第6章 睡眠呼吸中止症用设备市场规模与预测，2018～2026年，各终端用户

  • 主要调查结果
  • 与医院睡眠研究所
  • 居家照护

第7章 睡眠呼吸中止症用设备市场规模与预测，2018～2026年，各地区

  • 主要调查结果
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 比利时
    • 俄罗斯
    • 荷兰
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 新加坡
    • 马来西亚
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的亚太地区
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的南美
  • 中东·非洲
    • 阿拉伯联合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他的中东·非洲

第8章 企业简介

  • Fisher & Paykel Healthcare(纽西兰)
  • Koninklijke Philips(荷兰)
  • ResMed(美国)
  • Compumedics(澳洲)
  • Whole You(美国)
  • BMC Medical(中国)
  • Braebon Medical(加拿大)
  • Lowenstein Medical(德国)
  • Drive DeVilbiss Healthcare(美国)
  • SomnoMed(澳洲)
简介目录
Product Code: PM1597

The global sleep apnea devices market size is anticipated to reach USD 7.96 billion by 2032 growing at a CAGR of 5.9% from 2024 to 2032 according to a new report published by Polaris Market Research. The report 'Sleep Apnea Devices Market Share, Size, Trends & Industry Analysis Report, By Diagnostic Devices (PSG, Respiratory polygraphs, Pulse Oximeters, Actigraphy Devices); By Therapeutic Devices (PAP, Oxygen Devices, Oral Appliances); By End User; By Region: Segment Forecast, 2024 - 2032' provides insights on the current market scenario and the future prospects. In 2023, the Positive airway pressure (PAP) dominated the global Sleep Apnea Devices industry, in terms of revenue. North America was to be the leading contributor to the global market revenue in 2017.

Sleep apnea is an ailment which befalls when the brain as well as body obtain inadequate amount of oxygen where breathing process is interfered while sleeping. Obstructive Sleep Apnea (OSA) is the most common type of sleep apnea which is majorly triggered by airway blockage. Other forms of sleep apnea are central sleep apnea, and complex sleep apnea syndrome. In order to avoid such disease, it is essential to perform diagnostic tests on the patient to classify the appropriate therapeutic devices for treatment. Sleep apnea is extensively observed in the elderly population. There are multiple instances where sleep apnea is kept un-diagnosed due to factors such as non-specific exhibition of the disorder and lack of awareness amongst the patients.

Growing frequency of this disease along with the increasing need for appropriate diagnosis and effective treatment, increasing responsiveness among individuals, and growing geriatric population are some of the major factors encouraging the industry growth. Moreover, technological advancements augmenting comfort and safety is expected to enhance the usage of device rates especially in developed economies such as North America, which in turn is estimated to drive the market growth.

The sleep apnea diagnosis industry has witnessed rapid surge during the past decade. The growth is been attributed to the continuous development in sleep apnea device usage. According to the World Health Organization (WHO) reports, about 100 million individuals are suffering from sleep apnea. In addition, obstructive sleep apnea and is a chronic disease that unfavorably affects health. According to the National Healthy Sleep Awareness Project reports, around 25 million people are affected by this disease alone in the U.S.

Occurrence of sleep apnea surges the risk of other ailments such as abnormal glucose metabolism, depression, diabetes, high blood pressure, systemic hypertension, heart disease, and strokes. This all disorders further rises the total healthcare cost weight on the nation. Increasing consciousness regarding the sleep apnea along with welfare of using sleep apnea devices are anticipated to upsurge the revenue growth during the near future.

The North America was estimated to hold the highest market share during 2017. The large market share is majorly attributed to due to the high occurrence of Sleep-Disordered Breathing (SDB). Moreover, there is also a growing awareness amongst the for the novel and technologically advanced sleep apnea devices that are driving the growth of market growth in North America.

Asia Pacific market is anticipated to be the fastest growing industry during the forecast period. Growing number of clinics and large number of undiagnosed patient pool are expected to form lucrative growth opportunity in the market. Key players present in this region are focusing on constructing favorable policies towards enhancing the consumer pool through introduction of advanced as and cost-effective devices which in turn is expected to provide robust growth opportunities in the market during the forecast period.

The well-known companies profiled in the Sleep Apnea Devices market report include Fisher & Paykel Healthcare (New Zealand), Koninklijke Philips (Netherlands), ResMed (US), Compumedics (Australia), Whole You (US), BMC Medical (China), Braebon Medical (Canada), Lowenstein Medical (Germany), Drive DeVilbiss Healthcare (US), and SomnoMed (Australia). These companies launch new products and collaborate with other leaders in the market to innovate and launch new products to meet the increasing needs and requirements of consumers.

Polaris Market Research has segmented the global Sleep Apnea Devices market on the basis of diagnostic devices, therapeutic devices, end user, and region:

Sleep Apnea Devices, Devices Outlook (Revenue, USD Billion, 2015 - 2026)

  • Diagnostics Devices
  • Polysomnography Devices (PSG)
  • Respiratory polygraphs
  • Pulse Oximeters
  • Actigraphy Devices
  • Therapeutics Devices
  • Positive Airway Pressure (PAP) Devices
  • Oxygen Devices
  • Oral Appliances
  • Adaptive Servo Ventilation (ASV) Devices

Sleep Apnea Devices, End User Outlook (Revenue, USD Billion, 2015 - 2026)

  • Hospitals & Sleep Laboratories
  • Home care settings

Sleep Apnea Devices, Regional Outlook (Revenue, USD Billion, 2015 - 2026)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Belgium
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Korea
  • Singapore
  • Malaysia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research Methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-away
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market Definition
  • 2.2. Market Segmentation

3. Sleep Apnea Devices Market Insights

  • 3.1. Sleep Apnea Devices - Industry snapshot
  • 3.2. Sleep Apnea Devices - Ecosystem analysis
  • 3.3. Sleep Apnea Devices Market Dynamics
    • 3.3.1. Sleep Apnea Devices - Market Forces
      • 3.3.1.1. Sleep Apnea Devices Market Driver Analysis
      • 3.3.1.2. Sleep Apnea Devices Market Restraint/Challenges analysis
      • 3.3.1.3. Sleep Apnea Devices Market Opportunity Analysis
  • 3.4. Industry analysis - Porter's five force
    • 3.4.1. Bargaining power of supplier
    • 3.4.2. Bargaining power of buyer
    • 3.4.3. Threat of substitute
    • 3.4.4. Threat of new entrant
    • 3.4.5. Degree of competition
  • 3.5. Sleep Apnea Devices Market PEST Analysis
  • 3.6. Sleep Apnea Devices Market Value Chain Analysis
  • 3.7. Sleep Apnea Devices Industry Trends
  • 3.8. Competitive Ranking Analysis, 2017

4. Sleep Apnea Devices Market Size and Forecast, 2018-2026 by Diagnostic Devices

  • 4.1. Key Findings
  • 4.2. Polysomnography Devices (PSG)
  • 4.3. Respiratory polygraphs
  • 4.4. Pulse Oximeters
  • 4.5. Actigraphy Devices

5. Sleep Apnea Devices Market Size and Forecast, 2018-2026 by Therapeutic Devices

  • 5.1. Key Findings
  • 5.2. Positive Airway Pressure (PAP) Devices
  • 5.3. Oxygen Devices
  • 5.4. Oral Appliances
  • 5.5. Adaptive Servo Ventilation (ASV) Devices

6. Sleep Apnea Devices Market Size and Forecast, 2018-2026 by End User

  • 6.1. Key Findings
  • 6.2. Hospitals & Sleep Laboratories
  • 6.3. Home care settings

7. Sleep Apnea Devices Market Size and Forecast, 2018-2026 by Region

  • 7.1. Key Findings
  • 7.2. North America
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. UK
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Belgium
    • 7.3.7. Russia
    • 7.3.8. Netherlands
    • 7.3.9. Rest of Europe
  • 7.4. Asia-Pacific
    • 7.4.1. China
    • 7.4.2. India
    • 7.4.3. Japan
    • 7.4.4. Korea
    • 7.4.5. Singapore
    • 7.4.6. Malaysia
    • 7.4.7. Indonesia
    • 7.4.8. Thailand
    • 7.4.9. Philippines
    • 7.4.10. Rest of Asia-Pacific
  • 7.5. Latin America
    • 7.5.1. Brazil
    • 7.5.2. Mexico
    • 7.5.3. Argentina
    • 7.5.4. Rest of LATAM
  • 7.6. Middle East & Africa
    • 7.6.1. UAE
    • 7.6.2. Saudi Arabia
    • 7.6.3. South Africa
    • 7.6.4. Rest of MEA

8. Company Profiles

  • 8.1. Fisher & Paykel Healthcare (New Zealand)
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Developments
  • 8.2. Koninklijke Philips (Netherlands)
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Developments
  • 8.3. ResMed (U.S.)
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Developments
  • 8.4. Compumedics (Australia)
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Developments
  • 8.5. Whole You (U.S.)
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Developments
  • 8.6. BMC Medical (China)
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Developments
  • 8.7. Braebon Medical (Canada)
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Developments
  • 8.8. Lowenstein Medical (Germany)
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Developments
  • 8.9. Drive DeVilbiss Healthcare (U.S.)
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Developments
  • 8.10. SomnoMed (Australia)
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Developments